NEO · Neogenomics Inc · Webcasts, Transcripts & Audio
$15.67
+0.38 (+2.49%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.98B
Shares
129.39M
Volume · Nov 19
37.05K
Avg daily vol (3M)
1.96M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Neogenomics Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Neogenomics Inc (NEO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-12-01
Neogenomics Inc (NEO) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-12-01
Neogenomics Inc (NEO) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-17
Neogenomics Inc (NEO) November 17, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-28
Neogenomics Inc (NEO) Q3 2026 Earnings Call Transcript
Confident tone
NGS growth and portfolio mix
MRD launch and reimbursement
Margin expansion and operational excellence
Revenue
$209.25M
▲ 11.4% YoY Gross margin
46.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Neogenomics Inc (NEO) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-28
Neogenomics Inc (NEO) Q2 2026 Earnings Call Transcript
Positive tone
Raised full-year guidance
Clinical revenue and NGS growth
Commercial reorganization
Revenue
$201.66M
▲ 11.2% YoY Gross margin
45.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Neogenomics Inc (NEO) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-05-21
Neogenomics Inc (NEO) May 21, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-28
Neogenomics Inc (NEO) Q1 2026 Earnings Call Transcript
Confident tone
NGS portfolio and PanTracer
RaDaR ST MRD launch
Pathline acquisition and lab network
Revenue
$186.67M
▲ 11.1% YoY Gross margin
43.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-10
Neogenomics Inc (NEO) March 10, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-03
Neogenomics Inc (NEO) March 3, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-17
Neogenomics Inc (NEO) Q4 2025 Earnings Call Transcript
Positive tone
RADAR ST MRD launch
Clinical business growth
Pathline acquisition synergies
Revenue
$190.17M*
▲ 10.6% YoY Gross margin
43.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-01-13
Neogenomics Inc (NEO) January 13, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-10-28
Neogenomics Inc (NEO) Q3 2025 Earnings Call Transcript
Confident tone
Clinical growth and NGS momentum
MRD and RaDaR ST launch
Pathline acquisition and Northeast expansion
Revenue
$187.80M
▲ 11.9% YoY Gross margin
42.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Neogenomics Inc (NEO) Q2 2025 Earnings Call Transcript
Positive tone
NGS Growth and Mix
PanTracer Liquid Biopsy Launch
Pharma/Nonclinical Weakness
Revenue
$181.33M
▲ 10.2% YoY Gross margin
42.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Neogenomics Inc (NEO) Q1 2025 Earnings Call Transcript
Positive tone
NGS growth and product launches
Pathline acquisition and Northeast expansion
Leadership transition and culture
Revenue
$168.03M
▲ 7.5% YoY Gross margin
43.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-18
Neogenomics Inc (NEO) Q4 2024 Earnings Call Transcript
Confident tone
Clinical/NGS Growth
MRD Strategy and Partnerships
Adjusted EBITDA and Margin Expansion
Revenue
$172.00M*
▲ 10.6% YoY Gross margin
44.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Neogenomics Inc (NEO) Q3 2024 Earnings Call Transcript
Positive tone
NGS as Growth Driver
New Product Launches
Pharma / Clinical Services Turnaround
Revenue
$167.82M
▲ 10.4% YoY Gross margin
44.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-29
Neogenomics Inc (NEO) Q2 2024 Earnings Call Transcript
Confident tone
NGS and Advanced Diagnostics Innovation
MRD Strategy and R&D
Revenue Growth and Financial Performance
Revenue
$164.50M
▲ 12% YoY Gross margin
44.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
Neogenomics Inc (NEO) Q1 2024 Earnings Call Transcript
Confident tone
Clinical Services growth and NGS
Commercial organization and sales force expansion
Advanced Diagnostics / Pharma
Revenue
$156.24M
▲ 13.9% YoY Gross margin
41.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Neogenomics Inc (NEO) Q4 2023 Earnings Call Transcript
Confident tone
Revenue and EBITDA Growth
Clinical Services Performance
NGS Volume and Mix Shift
Revenue
$155.55M*
▲ 12.1% YoY Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Neogenomics Inc (NEO) Q3 2023 Earnings Call Transcript
Revenue
$151.95M
▲ 18% YoY Gross margin
41.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Neogenomics Inc (NEO) Q2 2023 Earnings Call Transcript
Revenue
$146.92M
▲ 17.5% YoY Gross margin
40.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Neogenomics Inc (NEO) Q1 2023 Earnings Call Transcript
Revenue
$137.22M
▲ 17.1% YoY Gross margin
39.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Neogenomics Inc (NEO) Q4 2022 Earnings Call Transcript
Revenue
$138.71M*
▲ 10.3% YoY Gross margin
41.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Neogenomics Inc (NEO) Q3 2022 Earnings Call Transcript
Revenue
$128.78M
▲ 6.1% YoY Gross margin
38.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Neogenomics Inc (NEO) Q2 2022 Earnings Call Transcript
Revenue
$125.07M
▲ 2.8% YoY Gross margin
35.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Neogenomics Inc (NEO) Q1 2022 Earnings Call Transcript
Revenue
$117.17M
▲ 1.4% YoY Gross margin
32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Neogenomics Inc (NEO) Q4 2021 Earnings Call Transcript
Revenue
$125.73M*
▼ 0.2% YoY Gross margin
36.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Neogenomics Inc (NEO) Q3 2021 Earnings Call Transcript
Revenue
$121.34M
▼ 3.3% YoY Gross margin
38.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Neogenomics Inc (NEO) Q2 2021 Earnings Call Transcript
Revenue
$121.72M
▲ 39.9% YoY Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Neogenomics Inc (NEO) Q1 2021 Earnings Call Transcript
Revenue
$115.53M
▲ 9% YoY Gross margin
36.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Neogenomics Inc (NEO) Q4 2020 Earnings Call Transcript
Revenue
$126.00M*
▲ 17.9% YoY Gross margin
45.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Neogenomics Inc (NEO) Q3 2020 Earnings Call Transcript
Revenue
$125.44M
▲ 19.8% YoY Gross margin
43.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Neogenomics Inc (NEO) Q2 2020 Earnings Call Transcript
Revenue
$86.98M
▼ 14.5% YoY Gross margin
32.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-09
Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript
Revenue
$106.03M
▲ 10.9% YoY Gross margin
43.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Neogenomics Inc (NEO) Q4 2019 Earnings Call
Revenue
$106.87M
▲ 39.7% YoY Gross margin
46.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–37 of 37 webcasts
Key facts
CIK
1077183
CUSIP
64049M209
13F (30d)
301 filings
280 filers
Visit website
Investor relations